JP6364426B2 - 未成熟血小板計算システム及び方法 - Google Patents
未成熟血小板計算システム及び方法 Download PDFInfo
- Publication number
- JP6364426B2 JP6364426B2 JP2015550823A JP2015550823A JP6364426B2 JP 6364426 B2 JP6364426 B2 JP 6364426B2 JP 2015550823 A JP2015550823 A JP 2015550823A JP 2015550823 A JP2015550823 A JP 2015550823A JP 6364426 B2 JP6364426 B2 JP 6364426B2
- Authority
- JP
- Japan
- Prior art keywords
- module
- count
- light
- immature
- vcs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 237
- 210000001772 blood platelet Anatomy 0.000 claims description 611
- 238000005259 measurement Methods 0.000 claims description 453
- 239000012472 biological sample Substances 0.000 claims description 254
- 210000003743 erythrocyte Anatomy 0.000 claims description 137
- 238000004820 blood count Methods 0.000 claims description 114
- 239000000523 sample Substances 0.000 claims description 92
- 238000004458 analytical method Methods 0.000 claims description 90
- 238000000149 argon plasma sintering Methods 0.000 claims description 74
- 210000000265 leukocyte Anatomy 0.000 claims description 73
- 238000004883 computer application Methods 0.000 claims description 52
- 239000012503 blood component Substances 0.000 claims description 50
- 238000012545 processing Methods 0.000 claims description 37
- 230000003287 optical effect Effects 0.000 claims description 31
- 238000011282 treatment Methods 0.000 claims description 28
- 239000002131 composite material Substances 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 17
- 238000001374 small-angle light scattering Methods 0.000 claims description 9
- 210000005096 hematological system Anatomy 0.000 claims description 7
- 230000002489 hematologic effect Effects 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 description 289
- 210000001995 reticulocyte Anatomy 0.000 description 143
- 238000012795 verification Methods 0.000 description 81
- 238000002847 impedance measurement Methods 0.000 description 72
- 238000001514 detection method Methods 0.000 description 58
- 230000001902 propagating effect Effects 0.000 description 55
- 210000004369 blood Anatomy 0.000 description 50
- 239000008280 blood Substances 0.000 description 50
- 230000000644 propagated effect Effects 0.000 description 28
- 239000000306 component Substances 0.000 description 27
- 230000008569 process Effects 0.000 description 23
- 230000035790 physiological processes and functions Effects 0.000 description 21
- 230000001413 cellular effect Effects 0.000 description 18
- 210000000601 blood cell Anatomy 0.000 description 16
- 238000004891 communication Methods 0.000 description 15
- 230000031700 light absorption Effects 0.000 description 14
- 230000005540 biological transmission Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 230000001678 irradiating effect Effects 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 10
- 239000000975 dye Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 230000015654 memory Effects 0.000 description 10
- 239000001045 blue dye Substances 0.000 description 8
- NZYCYASKVWSANA-UHFFFAOYSA-M new methylene blue Chemical compound [Cl-].CCNC1=C(C)C=C2N=C(C=C(C(NCC)=C3)C)C3=[S+]C2=C1 NZYCYASKVWSANA-UHFFFAOYSA-M 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 210000001185 bone marrow Anatomy 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000004962 physiological condition Effects 0.000 description 5
- 230000002028 premature Effects 0.000 description 5
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 4
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 4
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 239000013610 patient sample Substances 0.000 description 4
- 238000007781 pre-processing Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000004159 blood analysis Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 210000003593 megakaryocyte Anatomy 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 206010043554 thrombocytopenia Diseases 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 2
- 201000007023 Thrombotic Thrombocytopenic Purpura Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000009652 hydrodynamic focusing Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 208000013544 Platelet disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- -1 display system (s) Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000011527 multiparameter analysis Methods 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000035921 thrombopoiesis Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N15/0205—Investigating particle size or size distribution by optical means
- G01N15/0211—Investigating a scatter or diffraction pattern
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects
- G01N15/12—Investigating individual particles by measuring electrical or magnetic effects by observing changes in resistance or impedance across apertures when traversed by individual particles, e.g. by using the Coulter principle
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
- G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/018—Platelets
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Ecology (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261747734P | 2012-12-31 | 2012-12-31 | |
| US61/747,734 | 2012-12-31 | ||
| US14/142,369 | 2013-12-27 | ||
| PCT/US2013/078135 WO2014106132A1 (en) | 2012-12-31 | 2013-12-27 | Immature platelet enumeration systems and methods |
| US14/142,369 US9939453B2 (en) | 2012-12-31 | 2013-12-27 | Immature platelet enumeration systems and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016511391A JP2016511391A (ja) | 2016-04-14 |
| JP2016511391A5 JP2016511391A5 (enExample) | 2017-01-19 |
| JP6364426B2 true JP6364426B2 (ja) | 2018-07-25 |
Family
ID=51017595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015550823A Expired - Fee Related JP6364426B2 (ja) | 2012-12-31 | 2013-12-27 | 未成熟血小板計算システム及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9939453B2 (enExample) |
| EP (1) | EP2939000A1 (enExample) |
| JP (1) | JP6364426B2 (enExample) |
| KR (1) | KR20150103005A (enExample) |
| CN (1) | CN104903699A (enExample) |
| BR (1) | BR112015015400A2 (enExample) |
| WO (1) | WO2014106132A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160266028A1 (en) * | 2014-07-18 | 2016-09-15 | Wyatt Technology Corporation | Method to measure the structure of small particles in solution |
| EP3408773B1 (en) | 2016-01-28 | 2023-09-20 | Beckman Coulter, Inc. | Infection detection and differentiation systems and methods |
| CN108463722B (zh) * | 2016-03-30 | 2021-09-21 | 西门子医疗保健诊断公司 | 用于处理血小板细胞数据的系统、方法和设备 |
| KR101895760B1 (ko) * | 2016-06-27 | 2018-09-06 | (주)뉴옵틱스 | 혈구 분석 시스템 및 그의 제어방법 |
| KR20190120318A (ko) | 2017-02-28 | 2019-10-23 | 베크만 컬터, 인코포레이티드 | 상호 운용 질병 관리 시스템 |
| US11852640B2 (en) | 2017-10-27 | 2023-12-26 | Beckman Coulter, Inc. | Hematology analyzers and methods of operation |
| US11521706B2 (en) | 2018-04-20 | 2022-12-06 | Beckman Coulter, Inc. | Testing and representing suspicion of sepsis |
| US11538566B2 (en) | 2018-05-23 | 2022-12-27 | Beckman Coulter, Inc. | Sample analysis with test determination based on identified condition |
| CN112041938A (zh) | 2018-04-20 | 2020-12-04 | 拜克门寇尔特公司 | 败血症感染确定系统和方法 |
| WO2019206313A1 (zh) | 2018-04-28 | 2019-10-31 | 深圳迈瑞生物医疗电子股份有限公司 | 测定血小板浓度的方法及系统 |
| EP3806712A1 (en) | 2018-06-15 | 2021-04-21 | Beckman Coulter, Inc. | Method of determining sepsis in the presence of blast flagging |
| BE1026632B1 (nl) | 2018-09-18 | 2020-04-16 | Optimum Nv | Sorteerapparaat |
| JP7657195B2 (ja) | 2019-07-12 | 2025-04-04 | ベックマン コールター， インコーポレイテッド | 収縮期血圧、血液パラメーター、およびこれらの組み合わせを含むバイタルサインを使用して敗血症を検出する方法 |
| EP3997461A1 (en) | 2019-07-12 | 2022-05-18 | Beckman Coulter, Inc. | Systems and methods for evaluating immune response to infection |
| JP7660094B2 (ja) | 2019-07-12 | 2025-04-10 | ベックマン コールター， インコーポレイテッド | 感染に対する免疫応答を評価するためのシステムおよび方法 |
| CN114787625A (zh) * | 2019-12-12 | 2022-07-22 | 思迪赛特诊断有限公司 | 检测血液样品中的血小板 |
| WO2021133686A1 (en) | 2019-12-27 | 2021-07-01 | Beckman Coulter, Inc. | Sample preparation instrument |
| WO2021216752A1 (en) | 2020-04-21 | 2021-10-28 | Beckman Coulter, Inc. | Detection of medical condition, severity, risk, and acuity using parameters |
| US20230393164A1 (en) | 2020-09-25 | 2023-12-07 | Beckman Coulter, Inc. | Methods for evaluating mis-c associated with covid-19 |
| US20220167887A1 (en) | 2020-12-02 | 2022-06-02 | Beckman Coulter, Inc. | Method of Detecting Sepsis Using Primary and Secondary Hematology Parameters |
| US20250226104A1 (en) | 2022-02-18 | 2025-07-10 | Beckman Coulter, Inc. | Detection of sepsis using hematology parameters |
| WO2025014722A1 (en) | 2023-07-07 | 2025-01-16 | Cepheid | Systems and methods for ai based infection classification |
| WO2025014723A1 (en) | 2023-07-07 | 2025-01-16 | Cepheid | Systems and methods for ai based infection classification |
| WO2025240490A1 (en) | 2024-05-13 | 2025-11-20 | Beckman Coulter, Inc. | Detection of bacteremia using hematology parameters |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970007077B1 (ko) | 1987-03-13 | 1997-05-02 | 코울터 일렉트로닉스 인커퍼레이티드 | 광산란 기술을 이용한 다중-부분식별 분석 방법 |
| DE69432410T2 (de) | 1993-05-14 | 2004-03-04 | Coulter International Corp., Miami | Retikulozyt bestimmungsverfahren und geraet, das lichtstreuungstechniken verwendet |
| US5891734A (en) | 1994-08-01 | 1999-04-06 | Abbott Laboratories | Method for performing automated analysis |
| JP4136017B2 (ja) | 1996-09-19 | 2008-08-20 | シスメックス株式会社 | 粒子分析装置 |
| US6133995A (en) | 1997-05-09 | 2000-10-17 | Sysmex Corporation | Particle measuring apparatus |
| US6060322A (en) | 1998-10-20 | 2000-05-09 | Coulter International Corp. | Method for identification of reticulated cells |
| JP4101994B2 (ja) | 1999-01-21 | 2008-06-18 | シスメックス株式会社 | 粒子分析装置および自動粒子分析方法 |
| US6228652B1 (en) * | 1999-02-16 | 2001-05-08 | Coulter International Corp. | Method and apparatus for analyzing cells in a whole blood sample |
| CA2367780A1 (en) | 1999-03-31 | 2000-10-05 | Bayer Corporation | Single channel, single dilution detection method |
| US6894779B2 (en) | 2002-08-23 | 2005-05-17 | Coulter International Corp. | Apparatus for detecting back-scatter in a laser-based blood analysis system |
| US6743634B2 (en) | 2002-08-23 | 2004-06-01 | Coulter International Corp. | Method and apparatus for differentiating blood cells using back-scatter |
| US6955872B2 (en) | 2003-03-20 | 2005-10-18 | Coulter International Corp. | Dye compositions which provide enhanced differential fluorescence and light scatter characteristics |
| US7674598B2 (en) | 2004-05-21 | 2010-03-09 | Beckman Coulter, Inc. | Method for a fully automated monoclonal antibody-based extended differential |
| US7390662B2 (en) | 2005-11-09 | 2008-06-24 | Beckman Coulter, Inc. | Method and apparatus for performing platelet measurement |
| US9243993B2 (en) | 2005-03-17 | 2016-01-26 | Sysmex Corporation | Sample analyzer and sample analyzing method |
| US7580120B2 (en) | 2005-04-07 | 2009-08-25 | Sysmex Corporation | Blood analyzer, sample analyzer, and flow cytometer |
| JP4745030B2 (ja) | 2005-11-15 | 2011-08-10 | シスメックス株式会社 | 血液分析装置 |
| US7457709B2 (en) | 2005-12-20 | 2008-11-25 | Beckman Coulter, Inc. | Systems and methods for particle counting |
| JP5010443B2 (ja) | 2006-12-20 | 2012-08-29 | シスメックス株式会社 | 血球分析装置および血球分析方法 |
| JP4817450B2 (ja) | 2007-01-31 | 2011-11-16 | シスメックス株式会社 | 血液分析装置、血液分析方法およびコンピュータプログラム |
| EP3260842B1 (en) | 2007-02-01 | 2022-04-13 | Sysmex Corporation | Hematological analyzer and method for analyzing a sample |
| JP4948230B2 (ja) | 2007-03-29 | 2012-06-06 | シスメックス株式会社 | 試料分析装置および試料分析方法 |
| US9322834B2 (en) | 2007-05-30 | 2016-04-26 | Sysmex Corporation | Sample analyzer, blood analyzer and displaying method |
| JP5025371B2 (ja) * | 2007-07-31 | 2012-09-12 | シスメックス株式会社 | 血液分析装置 |
| WO2009058876A1 (en) | 2007-10-29 | 2009-05-07 | Beckman Coulter, Inc. | Method for a rapid antibody-based analysis of platelet populations |
| EP2889620B1 (en) | 2008-05-09 | 2017-10-11 | Sysmex Corporation | Blood analyzer, blood analysis method, hemolytic agent and staining agent |
| CN102016577B (zh) | 2008-05-09 | 2015-06-17 | 希森美康株式会社 | 血液分析装置,血液分析方法及溶血剂 |
| US8094299B2 (en) | 2008-07-24 | 2012-01-10 | Beckman Coulter, Inc. | Transducer module |
| US8603773B2 (en) * | 2008-09-19 | 2013-12-10 | Beckman Coulter | Method and system for analyzing a blood sample |
| US8417012B2 (en) | 2008-11-04 | 2013-04-09 | Beckman Coulter, Inc. | Non-linear histogram segmentation for particle analysis |
| US8192995B2 (en) | 2008-11-13 | 2012-06-05 | Beckman Coulter, Inc. | Method of correction of particle interference to hemoglobin measurement |
| ES2796655T3 (es) | 2008-11-14 | 2020-11-27 | Beckman Coulter Inc | Celdas de flujo óptico monolíticas y método de fabricación |
| US8906308B2 (en) | 2010-01-15 | 2014-12-09 | Abbott Laboratories | Method for determining volume and hemoglobin content of individual red blood cells |
-
2013
- 2013-12-27 US US14/142,369 patent/US9939453B2/en active Active
- 2013-12-27 CN CN201380068859.XA patent/CN104903699A/zh active Pending
- 2013-12-27 KR KR1020157016984A patent/KR20150103005A/ko not_active Abandoned
- 2013-12-27 WO PCT/US2013/078135 patent/WO2014106132A1/en not_active Ceased
- 2013-12-27 EP EP13824573.3A patent/EP2939000A1/en not_active Withdrawn
- 2013-12-27 BR BR112015015400A patent/BR112015015400A2/pt not_active Application Discontinuation
- 2013-12-27 JP JP2015550823A patent/JP6364426B2/ja not_active Expired - Fee Related
-
2018
- 2018-03-05 US US15/911,647 patent/US20180196070A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20180196070A1 (en) | 2018-07-12 |
| JP2016511391A (ja) | 2016-04-14 |
| US9939453B2 (en) | 2018-04-10 |
| WO2014106132A1 (en) | 2014-07-03 |
| BR112015015400A2 (pt) | 2017-07-11 |
| KR20150103005A (ko) | 2015-09-09 |
| US20140186874A1 (en) | 2014-07-03 |
| CN104903699A (zh) | 2015-09-09 |
| EP2939000A1 (en) | 2015-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6364426B2 (ja) | 未成熟血小板計算システム及び方法 | |
| JP6321637B2 (ja) | 白血球数の測定方法及び測定装置 | |
| KR102667169B1 (ko) | 감염 검출 및 감별 시스템들 및 방법들 | |
| KR101991989B1 (ko) | 응괴 조정을 갖는 혈소판 카운트를 위한 시스템들 및 방법들 | |
| US11852640B2 (en) | Hematology analyzers and methods of operation | |
| KR20150041130A (ko) | Cpd 데이터를 이용한 백혈병 분류 | |
| KR20150091049A (ko) | Cpd 데이터를 이용한 결핵 선별검사 | |
| EP2883036A2 (en) | Leukemia classification using cpd data | |
| EP2926113A1 (en) | Tuberculosis screening using cpd data |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161125 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161125 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170921 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170925 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171225 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180605 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180702 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6364426 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |